Overview
Corporate Profile
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Latest News
View All
Sep 10, 2020
Gamida Cell Presents Analysis of Observational Data Demonstrating the Impact of Donor Age in Hematopoietic Stem Cell Transplant Outcomes at the Virtual Cord Blood Connect Meeting
Read More
Sep 03, 2020
Gamida Cell Announces Two-Part Virtual Miniseries Focused on Omidubicel to Take Place in September
Read More
Aug 11, 2020
Gamida Cell Reports Second Quarter 2020 Financial Results and Provides Company Update
Read More
Aug 04, 2020
Gamida Cell Announces the Date of Its Second Quarter 2020 Financial Results and Webcast
Read More
Jul 21, 2020
Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer
Read More
Jun 12, 2020
Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum
Read More
May 26, 2020
Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read More
May 21, 2020
Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update
Read More
May 18, 2020
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
Read More
May 18, 2020
Gamida Cell Announces the Date of Its First Quarter 2020 Financial Results and Webcast
Read More
May 12, 2020
Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies
Read More
Mar 02, 2020
Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation
Read More
Feb 25, 2020
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
Read More
Feb 19, 2020
Gamida Cell Announces the Date of Its Full Year 2019 Financial Results and Webcast
Read More
Jan 02, 2020
Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel
Read More
Upcoming Events
More events are coming soon.
Recent Events
Corporate Fact Sheet
Corporate Presentation
Investor & Media Contact
Jaren Irene Madden
Vice President of Investor Relations and Corporate Communications
Gamida Cell Ltd.
IRPR@gamida-cell.com